Roundup: South Korea opens public medical data utilisation centres and more briefs
2023-05-26
South Korea designates 5 centres for public medical data analysis
The South Korean Ministry of Health and Welfare has officially launched designated centres for safe medical data utilisation.
The ministry has named five centres which have been equipped with physical, technical, and managerial security measures to allow the safe utilisation of public medical and clinical data for research purposes.
These centres are the Korea Health and Medical Information Service in Seoul, Keimyung University Dongsan Medical Center in Daegu, Wonju Severance Christian Hospital in Wonju, Chungnam National University Hospital in Chungnam, and the National Cancer Center (NCC) in Gyeonggi.
Moreover, the ministry announced that the use of cancer data from the NCC's K-CURE project via the data utilisation centres will begin in June.
South Korea expedites commercialisation of VR therapy for visual impairment
The South Korean Health Ministry has recently designated a VR-based software therapy visual impairment as an innovative medical device, accelerating its approval process.
Developed by local digital therapeutics company Nunaps, VIVID Brain is the first recognised South Korean DTx for improving visual impairment caused by brain damage. It provides visual perception training to enhance brain plasticity, veering from common sensory compensation and substitution techniques used to treat visual impairment.
South Korea recently made
changes in its approval process for novel medical devices
to hasten their use in clinical settings.
VIVID Brain is still undergoing proof-of-concept studies to further obtain clinical use clearance in South Korea.
Indonesia, Iran collaborate for telerobotic surgery
Indonesia and Iran have expanded their healthcare cooperation by launching a centre for telerobotic surgery.
The two governments have been testing the concept since 2021 at Hasan Sadikin Hospital in Bandung and Sardjito Hospital in Yogyakarta. It aims to eliminate geographical barriers to allow specialists to provide their services remotely to patients outside major cities and to collaborate with fellow specialists abroad. It also seeks to minimise post-surgical complications and reduce financial costs.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
靶点
-药物
-热门报告
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。